Pharmaceuticals stories
Regulated firms could keep data and encryption keys in Europe while using public cloud tools under the new model.
The new framework is intended to help firms prove AI tools are reliable and compliant as regulators demand ongoing evidence, not one-off audits.
Most firms are still increasing AI budgets, even as 57% of CX leaders say the technology has delivered little or no impact on operations.
After a year of security awareness training, only 5.3% of workers in Australia and New Zealand were likely to engage with phishing attempts.
Large enterprises can now buy Aily's AI decision agents via AWS Marketplace, cutting procurement friction and deployment time to as little as one day.
Plant operators can now connect mixed equipment more easily as Yokogawa adds multi-vendor support and tighter security to its OpreX server.
It underscores Fuel's push to tighten its systems and cyber defences as North American logistics operators face rising pressure for speed and visibility.
Field sales teams will get AI-generated call plans in seconds as Sanofi expands Snowflake use across research, procurement and operations.
The platform targets manual drug-development bottlenecks, from trial documents to safety case intake, as biopharma seeks faster compliant workflows.
The rankings bolster Altimetrik's push to win larger contracts from drugmakers as life sciences firms seek AI that improves regulated operations.
Industrial operators may get faster AI access to plant and business data, as the deal avoids copying information into separate systems.
QuEra survey finds quantum buyers and backers are demanding stronger proof of value, even as 46% of organisations expect budgets to stay flat.
The new specialisation should help healthcare and life sciences firms use governed AI and data tools to speed trials, discovery and patient insights.
The appointment comes as Scotland's digital sector contributes GBP £7.5 billion to the economy and faces pressure to fill 13,000 annual vacancies.
Rising regulatory scrutiny is pushing more buyers towards layered checks, after Liminal named Shufti a leader in age verification and estimation.
AI use is spreading across Canadian business, with AWS Canada saying 65% now use it, mostly for routine workflow and content tasks.
Artificial intelligence has become the main driver of UK tech value, with venture funding and start-up creation increasingly concentrated in the sector.
The funding will help London-based Apoha commercialise a liquid data layer already used by Boehringer Ingelheim and other pharma groups.
The hire strengthens ThreeSixty's push to meet rising demand for supply chain modelling as retailers and manufacturers seek lower freight costs.
The platform is aimed at regulated industries and sensitive data users, with on-premise and air-gapped deployment to keep control in-house.
